MedPath

A comparison of vilanterol/Fluticasone furoate with Formoterol/Budesonide in the management of bronchial asthma

Phase 3
Conditions
Health Condition 1: J00-J99- Diseases of the respiratory systemHealth Condition 2: J453- Mild persistent asthma
Registration Number
CTRI/2024/03/064848
Lead Sponsor
SRM College of Pharmacy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. patients with stable bronchial asthma

2. patients who already receiving prescription with formoterol /budesonide

Exclusion Criteria

1. patients with asthma /copd overlap

2. patients with bronchiectasis

3. patients with allergic bronchopulmonary aspergillosis

4.history of smoking

5.pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath